Expression of activity-dependent neuroprotective protein in the brain of adult rats

Histology and Histopathology

Volumn 23, Issue 3, 2008, Pages 309-317

  Gennet, N ^a   Herden, C ^b   Bubb, V J ^a   Quinn, J P ^a   Kipar, A ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

Activity dependent neuroprotective protein; Dissociated hippocampal cultures; Rat brain

Indexed keywords

HOMEODOMAIN PROTEIN; NERVE PROTEIN;

ANIMAL; ARTICLE; ASTROCYTE; BRAIN; CELL CULTURE; FEMALE; HELA CELL; HIPPOCAMPUS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MOTONEURON; NERVE CELL; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; ASTROCYTES; BRAIN; CELLS, CULTURED; FEMALE; HELA CELLS; HIPPOCAMPUS; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MOTOR NEURONS; NERVE TISSUE PROTEINS; NEURONS; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 84863987458     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Ashur-Fabian O., Segal-Ruder Y., Skutelsky E., Brenneman D.E., Steingart R.A., Giladi E. and Gozes I. (2003). The neuroprotective peptide NAP inhibits the aggregation of the beta-amyloid peptide. Peptides 24, 1413-1423.
2. Baeuerle P.A. and Baltimore D. (1988). Activation of DNA-binding activity in an apparently cytoplasmic precursor or the NF-kappa B transcription factor. Cell 53, 211-217.
3. Bassan M., Zamostiano R., Davidson A., Pinhasov A., Giladi E., Perl O., Bassan H., Blat C., Gibney G., Glazner G., Brenneman D.E. and Gozes I. (1999). Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide. J. Neurochem. 72, 1283-1293.
4. Beni-Adani L., Gozes I., Cohen Y., Assaf Y., Steingart R.A., Brenneman D.E., Eizenberg O., Trembolver V. and Shohami E. (2001). A peptide derived from activity-dependent neuroprotective protein (ADNP) ameliorates injury response in closed head injury in mice. J. Pharmacol. Exp. Ther. 296, 57-63.
5. Brenneman D.E. and Gozes I. (1996). A femtomolar-acting neuroprotective peptide. J. Clin. Invest. 97, 2299-2307.
6. Brenneman D.E., Hauser J., Neale E., Rubinraut S., Fridkin A., Davidson A. and Gozes I. (1998). Activity-dependent neurotrophic factor: structure-activity relationships of femtomolar-acting peptides. J. Pharmacol. Exp. Ther. 285, 619-627.
7. Cammermeyer J. (1961). The importance of avoiding dark neurons in experimental neuropathology. Acta Neuropathol. 1, 245-270.
8. Csordas A., Mazlo M. and Gallyas F. (2003). Recovery versus death of dark (compacted) neurons in non-impaired parenchymal environment: light and electron microscopic observations. Acta Neuropathol. 106, 37-49.
9. Dangoor D., Giladi E., Fridkin M. and Gozes I. (2005). Neuropeptide receptor transcripts are expressed in the rat clitoris and oscillate during the estrus cycle in the rat vagina. Peptides 26, 2579-2584.
10. Divinski I., Mittelman L. and Gozes I. (2004). A femtomolar acting octapeptide interacts with tubulin and protects astrocytes against zinc intoxication. J. Biol. Chem. 279, 28531-28538.
11. Furman S., Steingart R.A, Mandel S., Hauser J.M., Brenneman D.E. and Gozes I. (2004). Subcellular localisation and secretion of activity-dependent neuroprotective protein in astrocytes. Neuron Glia Biol. 1, 193-199.
12. Furman S., Hill J.M., Vulih I., Zaltzman R., Hauser J.M., Brenneman D.E. and Gozes I. (2005). Sexual dimorphism of activity-dependent neuroprotective protein in the mouse arcuate nucleus. Neurosci. Lett. 373, 73-78.
13. Gozes I., Bassan M., Zamostiano R., Pinhasov A., Davidson A., Giladi E., Perl O., Glazner G.W. and Brenneman D.E. (1999). A novel signaling molecule for neuropeptide action: activity-dependent neuroprotective protein. Ann. NY Acad. Sci. 897, 125-135.
14. Gozes I., Zamostiano R., Pinhasov A., Bassan M., Giladi E., Steingart R.A. and Brenneman D.E. (2000). A novel VIP responsive gene. Activity dependent neuroprotective protein. Ann. NY Acad. Sci. 921, 115-118.
15. Gozes I., Zaltzman R., Hauser J., Brenneman D.E., Shohami E., and Hill J.M. (2005). The expression of activity-dependent neuroprotective protein (ADNP) is regulated by brain damage and treatment of mice with the ADNP derived peptide, NAP, reduces the severity of traumatic head injury. Curr. Alzheimer Res. 2, 149-153.
16. Hüsken D., Asselbergs F., Kinzel M., Natt F., Weiler J., Martin P., Haner R. and Hall J. (2003) mRNA fusion constructs serve in a general cell-based assay to profile oligonucleotide activity. Nucleic Acids Res. 31, e102.
17. Kipar A., Baumgärtner W., Vogl C., Gaedke K. and Wellman M. (1998). Immunohistochemical characterization of inflammatory cells in brains of dogs with granulomatous meningoencephalitis. Vet. Pathol. 35, 43-52.
18. Leker R.R., Teichner A., Gridoriadis N., Ovadia H., Brenneman D.E., Fridkin M., Giladi E., Romano J. and Gozes I. (2002). NAP, a femtomolar-acting peptide, protects the brain against ischemic injury by reducing apoptotic death. Stroke 33, 1085-1092.
19. Merchenthaler I., Lopez F.J. and Negro-Vilar A. (1993). Anatomy and physiology of central galanin-containing pathways. Prog. Neurobiol. 40, 711-769.
20. Miao Q., Baumgärtner W., Failing K. and Alldinger S. (2003). Phase-dependent expression of matrix metalloproteinases and their inhibitors in demyelinating canine distemper encephalitis. Acta Neuropathol. 106, 486-494.
21. Nambu T., Sakurai T., Mizukami K., Hosoya Y., Yanagisawa M. and Goto K. (1999). Distribution of orexin neurons in the adult rat brain. Brain Res. 827, 243-260.
22. Nedelec S., Foucher I., Brunet I., Boulliot C., Prochiantz A. and Trembleau A. (2004). Emx2 homeodomain transcription factor interacts with eukaryotic translation initiation factor 4E (eIF4e) in the axons of olfactory sensory neurons. Proc. Natl. Acad. Sci. USA 101, 10815-10820.
23. Pinhasov A., Mandel S., Torchinsky A., Giladi E., Pittel Z., Goldsweig A.M., Servoss S.J., Brenneman D.E. and Gozes I. (2003). Activity-dependent neuroprotective protein: a novel gene essential for brain formation. Brain Res. Dev. Brain Res. 144, 83-90.
24. Poggi S.H., Goodwin K., Hill J.M., Brenneman D.E., Tendi E., Schinelli S., Abebe D., Spong C.Y. (2003). The role of activity-dependent neuroprotective protein in a mouse model of fetal alcohol syndrome. Am. J. Obstet. Gynecol. 189, 790-793.
25. Romano J., Beni-Adani L., Nissenbaum O.L., Brenneman D.E., Shohami E. and Gozes I. (2002). A single administration of the peptide NAP induces long-term protective changes against the consequences of head injury: gene Atlas array analysis. J. Mol. Neurosci. 18, 37-45.
26. Sigalov E., Fridkin M., Brenneman D.E. and Gozes I. (2000). VIP-Related protection against lodoacetate toxicity in pheochromocytoma (PC12) cells: a model for ischemic/hypoxic injury. J. Mol. Neurosci. 15, 147-154.
27. Spong C.Y., Abebe D.T., Gozes I., Brenneman D.E. and Hill J.M. (2001). Prevention of fetal demise and growth restriction in a mouse model of fetal alcohol syndrome. J. Pharmacol. Exp. Ther. 297, 774-779.
28. Steingart R.A. and Gozes I. (2006). Recombinant activity-dependent neuroprotective protein protects cells against oxidative stress. Mol. Cell Endocrinol. 252, 148-153.
29. Zaltzman R., Alexandrovich A., Beni S.M., Trembovler V., Shohami E. and Gozes I. (2004). Brain injury-dependent expression of activity-dependent neuroprotective protein. J. Mol. Neurosci. 24, 181-187.
30. Zamostiano R., Pinhasov A., Gelber E., Steingart R.A., Seroussi E., Giladi E., Bassan M., Wollman Y., Eyre H.J., Mulley J.C., Brenneman D.E. and Gozes I. (2001). Cloning and characterization of the human activity-dependent neuroprotective protein. J. Biol. Chem. 276, 708-714.